Improvement of Blood Pressure Control by Adherence Check in Patients With Apparent Treatment-Resistant Hypertension: A Case Series.

adherence to medication hypertension pharmacist

Journal

Clinical medicine insights. Case reports
ISSN: 1179-5476
Titre abrégé: Clin Med Insights Case Rep
Pays: United States
ID NLM: 101531893

Informations de publication

Date de publication:
2020
Historique:
received: 04 11 2019
accepted: 26 11 2019
entrez: 29 2 2020
pubmed: 29 2 2020
medline: 29 2 2020
Statut: epublish

Résumé

Adherence to medications is an important challenge while treating chronic disease such as resistant hypertension, which is defined as uncontrolled blood pressure (BP) despite treatment with more than 3 antihypertensive drugs to achieve targets. It is possible that poor adherence is the most significant contributor to rates of pseudo-resistance among treated hypertensive patients. In this report, we describe 4 patients with apparent treatment-resistant hypertension, who received intervention to promote adherence by pharmacists who set the prescribed medicines in a weekly medication calendar and conducted a weekly pill count. The results showed that the intervention of pharmacists to medication adherence improved systolic BP in patients with apparent treatment-resistant hypertension; however, further controlled trials are required to strengthen supporting evidence.

Identifiants

pubmed: 32110128
doi: 10.1177/1179547620904884
pii: 10.1177_1179547620904884
pmc: PMC7026810
doi:

Types de publication

Case Reports

Langues

eng

Pagination

1179547620904884

Informations de copyright

© The Author(s) 2020.

Déclaration de conflit d'intérêts

Declaration of conflicting interests:The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Heart. 2014 Jun;100(11):855-61
pubmed: 24694797
Hypertension. 2018 Nov;72(5):e53-e90
pubmed: 30354828
Circulation. 2012 Apr 3;125(13):1635-42
pubmed: 22379110
Br J Gen Pract. 2018 Jun;68(671):e394-e400
pubmed: 29739776
Am J Hypertens. 2013 Dec;26(12):1452-8
pubmed: 23934709
Br J Gen Pract. 2019 Aug 29;69(686):e621-e628
pubmed: 31358495
Hypertension. 2011 May;57(5):898-902
pubmed: 21444835
Hypertension. 2013 Aug;62(2):218-25
pubmed: 23753412
N Engl J Med. 2005 Aug 4;353(5):487-97
pubmed: 16079372
J Hypertens. 2001 Feb;19(2):335-41
pubmed: 11212978
JAMA. 1996 May 22-29;275(20):1571-6
pubmed: 8622248
J Hum Hypertens. 2016 Feb;30(2):83-9
pubmed: 25947275
Am J Med. 2012 Sep;125(9):882-7.e1
pubmed: 22748400
Hypertension. 2014 Nov;64(5):1012-21
pubmed: 25259745
J Hypertens. 2017 Dec;35(12):2346-2357
pubmed: 28777133

Auteurs

Keiko Hosohata (K)

Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Takatsuki, Japan.

Ayaka Inada (A)

Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Takatsuki, Japan.

Saki Oyama (S)

Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Takatsuki, Japan.

Takashi Doi (T)

Doi Clinic, Kyoto, Japan.

Iku Niinomi (I)

Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Takatsuki, Japan.

Tomohito Wakabayashi (T)

Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Takatsuki, Japan.

Mayako Uchida (M)

Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Takatsuki, Japan.

Kazunori Iwanaga (K)

Education and Research Center for Clinical Pharmacy, Osaka University of Pharmaceutical Sciences, Takatsuki, Japan.

Hiroyuki Matsuoka (H)

Iida Health Center, Iida, Japan.

Classifications MeSH